Maria Yannaraki

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

A. Kazory, C. Courivaud, D. Ducloux, 2019, BMC Nephrology.

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis

C. Courivaud, D. Ducloux, Maria Yannaraki, 2021, Kidney International.

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2005, Kidney international.

Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation.

P. Tiberghien, E. Masson, Maria Yannaraki, 2010, Human immunology.

Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection *

P. Tiberghien, C. Ferrand, A. Duperrier, 2006, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial

J. Quenot, C. Binquet, G. Capellier, 2014, Trials.

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients

C. Courivaud, D. Ducloux, J. Bamoulid, 2022, Journal of Infection.

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status

C. Courivaud, D. Ducloux, Maria Yannaraki, 2021, Clinical kidney journal.